Grown Rogue International (GRUSF) Gains from Investment Securities (2012 - 2020)

Grown Rogue International's (GRUSF) quarterly Gains from Investment Securities came in at -$232760.0 in Q4 2020, down 998.55% quarter-over-quarter from $25904.0 in Q3 2020.

Grown Rogue International (GRUSF) Gains from Investment Securities (2012 - 2020) Analysis & Trends

Grown Rogue International's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$232760.0 for Q4 2020.

  • On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$232760.0 in Q4 2020; TTM through Oct 2020 was -$221820.0, a N/A change from a year earlier, with the FY2022 full-year figure at -$455674.0, changed N/A from the prior year.
  • Gains from Investment Securities eased to -$232760.0 in Q4 2020 per GRUSF's latest filing, from $25904.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $25904.0 in Q3 2020 and bottomed at -$720516.0 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.06 Bn 87.19 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.39 Bn 30.45 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.59 Bn 23.53 Bn 4.39 Bn
5 United Therapeutics 23.19 Bn 21.04 Bn 648.10 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn -
7 Viatris 20.27 Bn 18.46 Bn 1.16 Bn
8 Neurocrine Biosciences 18.00 Bn 16.69 Bn 800.70 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn
10 Grown Rogue International 97.47 Mn 83.77 Mn 3.96 Mn

Historic Data

Download Data
DateValue
Oct 31, 2020 -232,760.00
Oct 31, 2020 -232,760.00
Jul 31, 2020 25,904.00
Jul 31, 2020 25,904.00
Apr 30, 2020 5,954.00
Apr 30, 2020 5,954.00
Jan 31, 2020 -20,918.00
Jan 31, 2020 -20,918.00
Jan 31, 2019 -720,516.00
Jan 31, 2019 -720,516.00
Aug 31, 2015 -2.12 Mn
Aug 31, 2015 -2.12 Mn
May 31, 2015 43,247.39
May 31, 2015 43,247.39
May 31, 2012 237,272.14
May 31, 2012 237,272.14